
PROSTATE SCREENING PACKAGE
Our customised and cost-effective screening packages are designed around individual’s health profile — including age, family history, and known risk factors.​
1. Specialist Consultation
A focused discussion with a doctor to understand your health history, concerns, and risk profile.
2. Physical Examination (Rectal Examination)
This includes a digital rectal examination (DRE) to check for abnormalities in the prostate
3. Blood Tumour Markers
We screen for several cancer types based on your risk factors:
-
Liver: Alphafoeto protein (AFP)
-
Colon: Carcinoembryonic antigen (CEA)
-
Pancreas: CA19-9
-
Prostate: PSA
4. Colorectal Cancer Screening (Optional)
Faecal Immunochemical Test (FIT) may be recommended based on age and symptoms.
-
Faecal immunochemical test (FIT)
DR JONATHAN TEH YI HUI
Medical Director (CSR), Senior Consultant Radiation Oncologist
MBBS (SIN), FRCR (Clinical Oncology, UK), FAMS (Radiation Oncology)
Dr. Jonthan Teh is Medical Director and Senior Consultant Radiation Oncologist at Centre for Stereotactic Radiosurgery (CSR), bringing with him over 20 years of experience in cancer care. Previously a Consultant Radiation Oncologist at the National Cancer Centre Singapore (NCCS), He was the principal investigator of a phase II trial in stereotactic ablative body radiotherapy (SBRT) for low-intermediate risk prostate cancer from 2013 to 2017, which was Southeast Asia’s first trial of this non-invasive treatment technique for prostate cancer. He is a first co-author of the publication documenting the efficacy and safety of prostate SBRT in the Singapore population in the Asia-Pacific Journal of Clinical Oncology.A leading expert in the treatment of prostate cancers, he is deeply committed to delivering precise, compassionate care to each of his patients.


DR DANIEL TAN YAT HARN (PBM)
Director, Senior Consultant Radiation Oncologist
MBBS (SIN), FRCR (Clinical Oncology, UK), FAMS (Radiation Oncology),
MBA (Healthcare Management)
Dr. Daniel Tan is Medical Director and Senior Consultant Radiation Oncologist at Centre for Stereotactic Radiosurgery (CSR), bringing with him over 20 years of experience in cancer care. Previously a Consultant Radiation Oncologist at the National Cancer Centre Singapore (NCCS), he was instrumental in developing the region’s first advanced Spine, Prostate, and Liver SRS/SBRT programs, pioneering their introduction in Southeast Asia. Dr Daniel’s radiosurgery expertise extends beyond the shores of Singapore. In June 2024, Dr Daniel was elected to the Board of Directors of the International Stereotactic Radiosurgery Society (ISRS), the world’s largest radiosurgery professional organisation.